About Unlearn
Unlearn is a company based in San Francisco (United States) founded in 2017. Unlearn has raised $127.13 million across 6 funding rounds from investors including Mubadala, Invest Northern Ireland and Altimeter Capital. Unlearn offers products and services including Unlearn Platform and Digital Twin Generators. Unlearn operates in a competitive market with competitors including Ebenbuild, adsilico, Verto Health, ELEM Biotech and Virtonomy, among others.
- Headquarter San Francisco, United States
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Unlearn.Ai, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$127.13 M (USD)
in 6 rounds
-
Latest Funding Round
$50 M (USD), Series C
Jan 25, 2024
-
Investors
Mubadala
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Unlearn
Unlearn offers a comprehensive portfolio of products and services, including Unlearn Platform and Digital Twin Generators.
Generates digital twins for simulating patient outcomes in clinical trials.
Tools for predicting clinical variables and enhancing trial efficiency.
People of Unlearn
Unlock access to complete
Unlock access to complete
Funding Insights of Unlearn
Unlearn has successfully raised a total of $127.13M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Unlearn
Unlearn has secured backing from 15 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Mubadala, Invest Northern Ireland and Altimeter Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long/short equity hedge fund and VC fim
|
Locked | Locked | Locked | |
|
Venture capital firm focused on AI-driven companies
|
Locked | Locked | Locked | |
|
Wittington Ventures is engaged in investing in technology start-ups.
|
Locked | Locked | Locked |
Investor details for Unlearn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Unlearn
Investment portfolio details for Unlearn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Unlearn
Detailed financials for Unlearn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Unlearn Comparisons
Peer comparison for Unlearn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Unlearn
Unlearn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ebenbuild, adsilico, Verto Health, ELEM Biotech and Virtonomy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital twin-based precision therapy for ARDS ventilation is provided.
|
|
| Locked | Locked | Locked |
In-silico trial solutions for medical device testing are developed.
|
|
| Locked | Locked | Locked |
A digital twin platform for population health management is offered.
|
|
| Locked | Locked | Locked |
A simulation-based platform for virtual medical trials is provided.
|
|
| Locked | Locked | Locked |
Virtual patient simulations are provided for medical device development.
|
Detailed competitors of Unlearn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Unlearn
Complete news archive for Unlearn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unlearn
Unlearn was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Unlearn is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Steven Herne is the current CEO of Unlearn.
Unlearn is a funded company, having raised a total of $127.13M across 6 funding rounds to date.
Provider of AI-based clinical trial management software. It uses Artificial-Intelligence control arm in a trial to enable sponsors to reduce the number of subjects. The product digital twins is a computationally generated clinical record that describes what would have happened if a specific subject had received a procedure prescribed for the psychological benefit of the patient.
Unlearn's top competitors include Ebenbuild, Verto Health and Virtonomy.
Unlearn offers Unlearn Platform and Digital Twin Generators.
Unlearn has 15 investors. Key investors include Mubadala, Invest Northern Ireland, Altimeter Capital, Radical Ventures, and Wittington Ventures.